|
| 1 |
Cancer immunotherapy: special issue of BMB Reports in 2021
Shin, Eui-Cheol;
/
Korean Society for Biochemistry and Molecular Biology
, v.54, no.1, pp.1-1,
|
|
| 2 |
Hitting the complexity of the TIGIT-CD96-CD112R-CD226 axis for next-generation cancer immunotherapy
Jin, Hyung-seung;Park, Yoon;
/
Korean Society for Biochemistry and Molecular Biology
, v.54, no.1, pp.2-11,
|
|
| 3 |
Current understanding of cancer-intrinsic PD-L1: regulation of expression and its protumoral activity
Yadollahi, Pedram;Jeon, You-Kyoung;Ng, Wooi Loon;Choi, Inhak;
/
Korean Society for Biochemistry and Molecular Biology
, v.54, no.1, pp.12-20,
|
|
| 4 |
Cancer immunotherapy with T-cell targeting cytokines: IL-2 and IL-7
Kim, Ji-Hae;Lee, Kun-Joo;Lee, Seung-Woo;
/
Korean Society for Biochemistry and Molecular Biology
, v.54, no.1, pp.21-30,
|
|
| 5 |
The role of dendritic cells in tumor microenvironments and their uses as therapeutic targets
Kim, Chae Won;Kim, Kyun-Do;Lee, Heung Kyu;
/
Korean Society for Biochemistry and Molecular Biology
, v.54, no.1, pp.31-43,
|
|
| 6 |
Harnessing NK cells for cancer immunotherapy: immune checkpoint receptors and chimeric antigen receptors
Kim, Nayoung;Lee, Dong-Hee;Choi, Woo Seon;Yi, Eunbi;Kim, HyoJeong;Kim, Jung Min;Jin, Hyung-Seung;Kim, Hun Sik;
/
Korean Society for Biochemistry and Molecular Biology
, v.54, no.1, pp.44-58,
|
|
| 7 |
Genome editing of immune cells using CRISPR/Cas9
Kim, Segi;Hupperetz, Cedric;Lim, Seongjoon;Kim, Chan Hyuk;
/
Korean Society for Biochemistry and Molecular Biology
, v.54, no.1, pp.59-69,
|
|
| 8 |
Update of early phase clinical trials in cancer immunotherapy
Lee, Dae Ho;
/
Korean Society for Biochemistry and Molecular Biology
, v.54, no.1, pp.70-88,
|
|